CA2036844A1 - Aerosol permettant une liberation reglee de microspheres de procaterol - Google Patents
Aerosol permettant une liberation reglee de microspheres de procaterolInfo
- Publication number
- CA2036844A1 CA2036844A1 CA 2036844 CA2036844A CA2036844A1 CA 2036844 A1 CA2036844 A1 CA 2036844A1 CA 2036844 CA2036844 CA 2036844 CA 2036844 A CA2036844 A CA 2036844A CA 2036844 A1 CA2036844 A1 CA 2036844A1
- Authority
- CA
- Canada
- Prior art keywords
- microspheres
- formulation
- albumin
- propellant
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48501390A | 1990-02-22 | 1990-02-22 | |
US485,013 | 1990-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2036844A1 true CA2036844A1 (fr) | 1991-08-23 |
Family
ID=23926589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2036844 Abandoned CA2036844A1 (fr) | 1990-02-22 | 1991-02-21 | Aerosol permettant une liberation reglee de microspheres de procaterol |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2036844A1 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US8709484B2 (en) | 2000-05-10 | 2014-04-29 | Novartis Ag | Phospholipid-based powders for drug delivery |
US8715623B2 (en) | 2001-12-19 | 2014-05-06 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US8877162B2 (en) | 2000-05-10 | 2014-11-04 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
US9554993B2 (en) | 1997-09-29 | 2017-01-31 | Novartis Ag | Pulmonary delivery particles comprising an active agent |
-
1991
- 1991-02-21 CA CA 2036844 patent/CA2036844A1/fr not_active Abandoned
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8080263B2 (en) | 1997-09-29 | 2011-12-20 | Novartis Ag | Dispersion for pulmonary delivery of a bioactive agent |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6638495B2 (en) | 1997-09-29 | 2003-10-28 | Nektar Therapeutics | Stabilized preparation for use in metered dose inhalers |
US7205343B2 (en) | 1997-09-29 | 2007-04-17 | Dellamary Luis A | Stabilized bioactive preparations and method of use |
US7393544B2 (en) | 1997-09-29 | 2008-07-01 | Nektar Therapeutics | Dispersion for pulmonary delivery of a bioactive agent |
US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US9554993B2 (en) | 1997-09-29 | 2017-01-31 | Novartis Ag | Pulmonary delivery particles comprising an active agent |
US8877162B2 (en) | 2000-05-10 | 2014-11-04 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
US8709484B2 (en) | 2000-05-10 | 2014-04-29 | Novartis Ag | Phospholipid-based powders for drug delivery |
US9439862B2 (en) | 2000-05-10 | 2016-09-13 | Novartis Ag | Phospholipid-based powders for drug delivery |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US8715623B2 (en) | 2001-12-19 | 2014-05-06 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US9421166B2 (en) | 2001-12-19 | 2016-08-23 | Novartis Ag | Pulmonary delivery of aminoglycoside |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU603139B2 (en) | A new system for administration of liposomes to mammals | |
KR910004580B1 (ko) | 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물 | |
RU2162689C2 (ru) | Пролипосомные порошки для ингаляции | |
US5891469A (en) | Solid Coprecipitates for enhanced bioavailability of lipophilic substances | |
AU730216B2 (en) | Solid coprecipitates for enhanced bioavailability of lipophilic substances | |
Cook et al. | Novel sustained release microspheres for pulmonary drug delivery | |
AU756669B2 (en) | Compositions comprising cannabinoids | |
AU612591B2 (en) | Pharmaceutical formulations comprising microcapsules | |
US4610868A (en) | Lipid matrix carriers for use in drug delivery systems | |
EP0167825B1 (fr) | Nanobilles lipidiques comme véhicule pour médicaments destinés à l'administration orale | |
CA2036844A1 (fr) | Aerosol permettant une liberation reglee de microspheres de procaterol | |
KR20030011816A (ko) | 약학적 조제약 및 그 제조 방법 | |
JP2002510311A (ja) | トコフェロールにより安定化された吸引用プロリポソーム粉末 | |
WO1987005803A1 (fr) | COMPOSITIONS DE LIPOSOMES ET SUBSTANCES ACTIVES beta2-RECEPTRICES | |
KR101180181B1 (ko) | 나노 입자 및 그의 제조 방법 | |
JPH0776180B2 (ja) | 吸入アレルゲンを含有するアレルギー治療用リポソーム | |
Sirisha et al. | World Journal of Pharmaceutical Sciences | |
JPH11222424A (ja) | 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子 | |
JP3202704B2 (ja) | 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子 | |
Jin | Microsphere formulation strategies, cell uptake studies, and pharmacokinetics in rats | |
Kamble et al. | Zileuton-Liposomal Dry Powder for Inhalation: In-Vitro and In-Vivo Characterization | |
IL119176A (en) | Soluble coprecipitates for enhanced oral bioavailability of lipophilic substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |